SQZ Biotechnologies Company (SQZB)
OTCMKTS: SQZB · Delayed Price · USD
0.0500
0.00 (0.00%)
Apr 17, 2024, 12:00 AM EDT - Market closed

SQZB Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Cash & Equivalents
66.01145.82172.6641.5761.88
Short-Term Investments
00059.0347.34
Cash & Cash Equivalents
66.01145.82172.66100.6109.22
Cash Growth
-54.73%-15.55%71.63%-7.89%-
Receivables
031.891.870.87
Other Current Assets
2.191.822.28-0.66-1.27
Total Current Assets
68.2150.64176.83101.82108.81
Property, Plant & Equipment
29.3972.8952.0148.214.43
Other Long-Term Assets
2.312.632.312.322.31
Total Long-Term Assets
31.775.5254.3150.536.73
Total Assets
99.9226.15231.14152.35115.55
Accounts Payable
2.513.973.712.81.09
Deferred Revenue
0.7221.745.5840.8345.72
Current Debt
6.569.948.219.440
Other Current Liabilities
12.06-2.39-12.3-14.79-25.48
Total Current Liabilities
21.8433.2245.1938.2821.33
Long-Term Debt
20.9159.7638.8932.890
Other Long-Term Liabilities
09.219.8622.5931.36
Total Long-Term Liabilities
20.9168.9558.7555.4731.36
Total Liabilities
42.75102.18103.9493.7652.69
Total Debt
27.4769.6947.142.330
Debt Growth
-60.58%47.98%11.25%--
Retained Earnings
-274.97-195.51-126.77-76.25-44.05
Comprehensive Income
0000.03-0
Shareholders' Equity
57.15123.98127.2-73.52-43.54
Net Cash / Debt
38.5476.13125.5758.27109.22
Net Cash / Debt Growth
-49.37%-39.37%115.49%-46.65%-
Net Cash Per Share
1.342.7623.2434.1968.83
Working Capital
46.36117.41131.6463.5487.48
Book Value Per Share
1.984.5023.55-43.13-27.44
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).